Equicord Is A Multidisciplinary Company Founded In 2012 By A Team Of Veterinariansbiologistsengineersand Pharmacistsit Specializes In The Researchdevelopmentmanufacturingand Commercialization Of Stem Cell Based Medicines For Animalspositioning Itself As A Leader In Advanced Veterinary Therapiesparticularly In Regenerative Medicine The Company Has Developed Notable Products Such As Horstemwhich Received The First European License For A Drug Based On Equine Umbilical Cord Mesenchymal Stem Cells In 2019And Dogstemthe First Stem Cell Based Medicine For Treating Canine Osteoarthritisauthorized In 2022Equicord Emphasizes Scientific Rigor In Its Mission To Create Innovative And Effective Therapies That Enhance The Quality Of Life For Animals Globallythe Company Operates State Of The Art Gmp Facilities And Collaborates With Established Partners Like Da Mes Pharma To Expand Its Reach In The Veterinary Pharmaceutical Market
